Home › NCT07566611

Primary Ciliary Dyskinesia in Adult Bronchiectasis

Novel Use of Combined High-Speed Video Microscopy and Nasal Nitric Oxide Screening for Identification of Primary Ciliary Dyskinesia in Adult Bronchiectasis

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults (≥18) with CT-confirmed bronchiectasis

Exclusion Criteria:

* Pre-existing diagnosis of cystic fibrosis
* Pre-existing diagnosis of primary ciliary dyskinesia
* Inability to perform testing
* Refusal of consent

About the study

The purpose of this study is to help determine how often primary ciliary dyskinesia (PCD) is present but undiagnosed in adults with bronchiectasis.

What is being tested

• Nasal Nitric Oxide Measurement (procedure)
• Nasopharyngeal (Nasal) Samples (procedure)

Sponsor: Indiana University · Participants: 60 · Started: Jul 17, 2026

Contact the study team

• Kenzie Mahan · Phone: 3172748899
• Lisa Bendy · Phone: (317) 278-7152

Official record on ClinicalTrials.gov — NCT07566611

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.